Shattuck Labs Inc (NAS:STTK)
$ 7.915 0.075 (0.96%) Market Cap: 376.37 Mil Enterprise Value: 265.75 Mil PE Ratio: 0 PB Ratio: 2.92 GF Score: 62/100

Shattuck Labs Inc at Cowen Health Care Conference Transcript

Mar 06, 2023 / 02:10PM GMT
Release Date Price: $3.55 (-8.27%)
Unidentified Analyst

I owe agents of -- we've got quite a panel over there. This is very awkward being on this side. Normally, I'm on that side of the room. It's very awkward being over here. So from Gritstone bio, we have CEO Andrew Allen; from IO Biotech, CEO Mai-Britt Zocca; from Janux Therapeutics, CEO David Campbell; from Shattuck Labs, their CMO Lini Panditel; and then Rob Ross, CEO of Surface; and Rene Russo, CEO of Xilio.

Maybe to start off with just -- IO field had -- you had an explosion of programs in the 2010s, some of which have certainly disappointed. This lead, in many cases, to investors becoming cynical about early-stage IO programs.

Questions & Answers

Unidentified Analyst;Andrew Allen
Gritstone bio, Inc. - CEO<

It's a bit -- just to start off with on a general question for the panel, what -- maybe Andrew will have -- you respond first. But just what do you think the field has learned? How has it changed? And was it now the right time for investors to re-evaluate the IO space and maybe come back to the IO space?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot